• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    ---
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMCKPF
Mallinckrodt PLC
1.6M
0.0x
---
United StatesNDOI
Endo Inc
1.9B
0.4x
---
United StatesEBS
Emergent BioSolutions Inc
635.8M
-1.0x
---
United StatesAMRX
Amneal Pharmaceuticals Inc
2.7B
-14.0x
---
United StatesTLRY
Tilray Brands Inc
1.3B
-5.4x
---
United StatesPCRX
Pacira Biosciences Inc
796.0M
-8.0x
---
As of 2024-11-09

Company Information

Mallinckrodt plc develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies. The Company operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its Specialty Generics segment is focused on providing its customers with specialty generic drugs and active pharmaceutical ingredients (APIs). The Company focuses on various therapeutic areas, such as autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, cultured skin substitutes and gastrointestinal products. Its product portfolio includes Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz, and Amitiza.

Contact Information

Headquarters
College Business & Technology Park Cruiserath, Blanchardstown, Dublin 15DUBLIN, Ireland
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Paul Bisaro
President, Chief Executive Officer, Director
Sigurdur Olafsson
Chief Financial Officer, Executive Vice President
Bryan Reasons
Executive Vice President, Chief Compliance Officer
Kassie Harrold
Executive Vice President, Chief Legal Officer, Corporate Secretary
Mark Tyndall

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6M
Revenue (TTM)
$2.0B
Shares Outstanding
19.7M
Mallinckrodt PLC does not pay a dividend.
Beta
---
EPS
$20.19
Book Value
$58.90
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
0.0x
Operating Margin
19.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.